Radiation lays down covering fire for viral shock troops
Radiation lays down covering fire for viral shock troops |
https://doi.org/10.18632/oncotarget.1187
Joan N Kyula,
Aadil A Khan,
Michelle J Wilkinson,
David Mansfield,
and Kevin J Harrington
|
1329-1330 |
Improving apoptotic responses to targeted therapy
Improving apoptotic responses to targeted therapy |
https://doi.org/10.18632/oncotarget.1261
Rizwan Haq,
and David E. Fisher
|
1331 |
Kinase Inhibitor Therapy in CML: It’s What’s Inside That Counts
Kinase Inhibitor Therapy in CML: It’s What’s Inside That Counts |
https://doi.org/10.18632/oncotarget.1271
Christopher A. Eide,
Brian J. Druker,
and Thomas O’Hare
|
1332-1333 |
Druggable Drivers of Lung Cancer
Druggable Drivers of Lung Cancer |
https://doi.org/10.18632/oncotarget.1223
Shameem Fawdar,
Zoe C. Edwards,
and John Brognard
|
1334-1335 |
Quo vadis, Kras? |
https://doi.org/10.18632/oncotarget.1322
Günter Schneider,
and Dieter Saur
|
1336-1337 |
DNA damage-induced ubiquitylation of proteasome controls its proteolytic activity
DNA damage-induced ubiquitylation of proteasome controls its proteolytic activity |
https://doi.org/10.18632/oncotarget.1060
Tatiana N Moiseeva,
Andrew Bottrill,
Gerry Melino,
and Nickolai A Barlev
|
1338-1348 |
Accumulation of autophagosomes in breast cancer cells induces TRAIL resistance through downregulation of surface expression of death receptors 4 and 5
Accumulation of autophagosomes in breast cancer cells induces TRAIL resistance through downregulation of surface expression of death receptors 4 and 5 |
https://doi.org/10.18632/oncotarget.1174
Xu Di,
Guofeng Zhang,
Yaqin Zhang,
Kazuyo Takeda,
Leslie A. Rivera Rosado,
and Baolin Zhang
|
1349-1364 |
Loss of PDCD4 contributes to enhanced chemoresistance in Glioblastoma Multiforme through de-repression of Bcl-xL translation
Loss of PDCD4 contributes to enhanced chemoresistance in Glioblastoma Multiforme through de-repression of Bcl-xL translation |
https://doi.org/10.18632/oncotarget.1154
Urszula Liwak,
Lindsay E Jordan,
Sally Davidson Von-Holt,
Poonam Singh,
Jennifer E. L. Hanson,
Ian A Lorimer,
Federico Roncaroli,
and Martin Holcik
|
1365-1372 |
Crucial Role for Early Growth Response-1 in the Transcriptional Regulation of miR-20b in Breast Cancer
Crucial Role for Early Growth Response-1 in the Transcriptional Regulation of miR-20b in Breast Cancer |
https://doi.org/10.18632/oncotarget.1165
Dongping Li,
Yaroslav Ilnytskyy,
Anna Kovalchuk,
Levon M. Khachigian,
Roderick T. Bronson,
Bo Wang,
and Olga Kovalchuk
|
1373-1387 |
Coordinated Targeting of the EGFR Signaling Axis by MicroRNA-27a*
Coordinated Targeting of the EGFR Signaling Axis by MicroRNA-27a* |
https://doi.org/10.18632/oncotarget.1239
Xiaoli Wu,
Mihir K. Bhayani,
Cristina T. Dodge,
Milena S. Nicoloso,
Yunyun Chen,
Xiaofeng Yan,
Makoto Adachi,
Ligy Thomas,
Chad E. Galer,
Tilahun Jiffar,
Curtis R. Pickering,
Michael E. Kupferman,
Jeffrey N. Myers,
George A. Calin,
and Stephen Y. Lai
|
1388-1398 |
Repression of c-Kit by p53 is mediated by miR-34 and is associated with reduced chemoresistance, migration and stemness
Repression of c-Kit by p53 is mediated by miR-34 and is associated with reduced chemoresistance, migration and stemness |
https://doi.org/10.18632/oncotarget.1202
Helge Siemens,
Rene Jackstadt,
Markus Kaller,
and Heiko Hermeking
|
1399-1415 |
A Hidden Role of the Inactivated FANCD2: Upregulating ΔNp63
A Hidden Role of the Inactivated FANCD2: Upregulating ΔNp63 |
https://doi.org/10.18632/oncotarget.1217
Jayabal Panneerselvam,
Anna Pickering,
Jun Zhang,
Hong Wang,
Hui Tian,
Junnian Zheng,
and Peiwen Fei
|
1416-1426 |
Mdig de-represses H19 large intergenic non-coding RNA (lincRNA) by down-regulating H3K9me3 and heterochromatin
Mdig de-represses H19 large intergenic non-coding RNA (lincRNA) by down-regulating H3K9me3 and heterochromatin |
https://doi.org/10.18632/oncotarget.1155
Bailing Chen,
Miaomiao Yu,
Qingshan Chang,
Yongju Lu,
Chitra Thakur,
Danjun Ma,
Zhengping Yi,
and Fei Chen
|
1427-1437 |
CXXC5 (Retinoid-Inducible Nuclear Factor, RINF) is a Potential Therapeutic Target in High-Risk Human Acute Myeloid Leukemia
CXXC5 (Retinoid-Inducible Nuclear Factor, RINF) is a Potential Therapeutic Target in High-Risk Human Acute Myeloid Leukemia |
https://doi.org/10.18632/oncotarget.1195
Andrey Astori,
Hanne Kristin Fredly,
Thomas Aquinas Aloysius,
Lars Bullinger,
Véronique Mansat-De Mas,
Pierre de la Grange,
Francois Delhommeau,
Karen Marie Hagen,
Christian Récher,
Isabelle Dusanter-Fourt,
Stian Knappskog,
Johan Richard Lillehaug,
Frederic Pendino,
and Øystein Bruserud
|
1438-1448 |
Zoledronic acid inhibits macrophage/microglia-assisted breast cancer cell invasion
Zoledronic acid inhibits macrophage/microglia-assisted breast cancer cell invasion |
https://doi.org/10.18632/oncotarget.1201
Eva Rietkötter,
Kerstin Menck,
Annalen Bleckmann,
Katja Farhat,
Meike Schaffrinski,
Matthias Schulz,
Uwe-Karsten Hanisch,
Claudia Binder,
and Tobias Pukrop
|
1449-1460 |
Galectin-7 is epigenetically-regulated tumor suppressor in gastric cancer
Galectin-7 is epigenetically-regulated tumor suppressor in gastric cancer |
https://doi.org/10.18632/oncotarget.1219
Seok-Jun Kim,
Jung-Ah Hwang,
Jae Y. Ro,
Yeon-Su Lee,
and Kyung-Hee Chun
|
1461-1471 |
Isolation and genome-wide expression and methylation characterization of CD31+ cells from normal and malignant human prostate tissue
Isolation and genome-wide expression and methylation characterization of CD31+ cells from normal and malignant human prostate tissue |
https://doi.org/10.18632/oncotarget.1269
Wei Luo,
Hu Qiang,
Dan Wang,
Kristin K Deeb,
Yingyu Ma,
Carl D Morrison,
Song Liu,
Candace S Johnson,
and Donald L Trump
|
1472-1483 |
Dietary restriction-resistant human tumors harboring the PIK3CA-activating mutation H1047R are sensitive to metformin
Dietary restriction-resistant human tumors harboring the PIK3CA-activating mutation H1047R are sensitive to metformin |
https://doi.org/10.18632/oncotarget.1234
Silvia Cufi,
Bruna Corominas-Faja,
Eugeni Lopez-Bonet,
Rosa Bonavia,
Sonia Pernas,
Isabel Alvarez Lopez,
Joan Dorca,
Susana Martinez,
Norberto Batista Lopez,
Severina Dominguez Martinez,
Elisabet Cuyas,
Joana Visa,
Esther Rodriguez-Gallego,
Rosa Quirantes-Pine,
Antonio Segura-Carretero,
Jorge Joven,
Begona Martin-Castillo,
and Javier A Menendez
|
1484-1495 |
The AKT Inhibitor MK-2206 is Cytotoxic in Hepatocarcinoma Cells Displaying Hyperphosphorylated AKT-1 and Synergizes with Conventional Chemotherapy
The AKT Inhibitor MK-2206 is Cytotoxic in Hepatocarcinoma Cells Displaying Hyperphosphorylated AKT-1 and Synergizes with Conventional Chemotherapy |
https://doi.org/10.18632/oncotarget.1236
Carolina Simioni,
Alberto M. Martelli,
Alice Cani,
Rengul Cetin-Atalay,
James A. McCubrey,
Silvano Capitani,
and Luca M. Neri
|
1496-1506 |
Selective anticancer agents suppress aging in Drosophila
Selective anticancer agents suppress aging in Drosophila |
https://doi.org/10.18632/oncotarget.1272
Anton Danilov,
Mikhail Shaposhnikov,
Ekaterina Plyusnina,
Valeria Kogan,
Peter Fedichev,
and Alexey Moskalev
|
1507-1526 |
Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival
Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival |
https://doi.org/10.18632/oncotarget.1291
Aurelie Poli,
Jian Wang,
Olivia Domingues,
Jesús Planagumà,
Tao Yan,
Kai Ove Skaftnesmo,
Cecilie Brekke Rygh,
Frits Thorsen,
Emmet McCormack,
François Hentges,
Paal Henning Pedersen,
Jacques Zimmer,
Per Øyvind Enger,
and Martha Chekenya
|
1527-1546 |